Author Bio
Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries.
Follow @keithspeights
Curaleaf Holdings (OTC:CURLF) is on a roll. Shares are up 37% so far in 2021 after delivering a gain last year of 90%.
The multistate cannabis operator gave investors even more to like on Tuesday. Curaleaf announced its Q4 results after the market close and provided details about a major new acquisition. Here are the highlights from the company s Q4 update and why Curaleaf s future looks even brighter than its past.
Curaleaf s Q4 Growth Was Impressive, but 2021 Should Be Even Better fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Curaleaf Reports Record Fourth Quarter and Fiscal Year End 2020 Financial and Operational Results
Record Fiscal Year and Fourth Quarter 2020 Pro Forma Revenue(1)(2) of $767.1 Million and $238.8 Million, Respectively
Record Fiscal Year and Fourth Quarter 2020 Managed Revenue(1) of $653.0 Million, up 161% from 2019 and $233.3 Million, up 186% from 2019, Respectively
Record Fiscal Year and Fourth Quarter 2020 Adjusted EBITDA(1) of $144.1 Million up 456% from 2019 and $53.8 Million up 289% from 2019, Respectively, as Operations Across 23 States Continue to Scale
Raised $289.8 Million of Net Proceeds from a Common Stock Offering and Debt Offering in January 2021, Providing the Company with Capital to Pursue Additional Organic and Inorganic Growth Opportunities
News provided by
Share this article